Table 2.
Bowel and urinary domain scores using EPIC questionnaire and scoring system by treatment group at a median follow-up of 50.3 months (IQR: 47.8–52.0 months).
| No IGRT |
IGRT-S |
IGRT-R |
||||
|---|---|---|---|---|---|---|
| No. of pts with data | Median (IQR) | No. of pts With data | Median (IQR) | No. of pts with data | Median (IQR) | |
| Bowel function | 29 | 96.4 (89.3–100) | 89 | 92.9 (85.7–96.4) | 75 | 96.4 (85.7–100) |
| P-value | 0.2101 | 0.5002 | ||||
| Bowel bother | 29 | 96.4 (87.5–100) | 83 | 92.9 (85.7–100) | 74 | 92.9 (85.7–100) |
| P-value | 0.4751 | 0.9092 | ||||
| Bowel summary | 29 | 94.6 (89.3–98.2) | 84 | 94.6 (87.5–96.4) | 74 | 92.9 (87.5–98.2) |
| P-value | 0.2181 | 0.5862 | ||||
| Urinary function | 28 | 97.5 (92.2–100) | 87 | 100 (89.2–100) | 75 | 95 (88.4–100) |
| P-value | 0.9411 | 0.4092 | ||||
| Urinary bother | 28 | 82.1 (74.1–93.8) | 80 | 85.7 (71.4–92.9) | 70 | 85.7 (75.9–92.9) |
| P-value | 0.9471 | 0.4562 | ||||
| Urinary incontinence | 27 | 100 (82.4–100) | 79 | 93.8 (85.5–100) | 71 | 93.8 (79.3–100) |
| P-value | 0.9851 | 0.4732 | ||||
| Irritative/Obstructive | 28 | 88.4 (78.6–96.0) | 79 | 89.3 (80.7–92.9) | 70 | 89.3 (85.7–96.4) |
| P-value | 0.8611 | 0.4542 | ||||
| Urinary summary | 27 | 88.9 (80.6–96.9) | 79 | 88.9 (78.7–95.8) | 71 | 89.6 (84–94.8) |
| P-value | 0.9451 | 0.7332 | ||||
| Vaizey total score | 27 | 4 (1–5.5) | 84 | 4 (1–7) | 72 | 4 (1–6) |
| 0.0481 | 0.8212 | |||||
1
Comparison of No IGRT and IGRT-S groups.
2
Comparison of IGRT-S and IGRT-R groups.